Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study
Authors:
- Ambrose O TalisunaATAmbrose O Talisuna
- Penny Grewal DaumeriePDPenny Grewal Daumerie
- Andrew BalyekuABAndrew Balyeku
- Timothy EganTETimothy Egan
- Bram PiotBPBram Piot
- Renia CoghlanRCRenia Coghlan
- Maud LugandMLMaud Lugand
- Godfrey BwireGBGodfrey Bwire
- John Bosco RwakimariJRJohn Bosco Rwakimari
- Richard NdyomugyenyiRNRichard Ndyomugyenyi
- Fred KatoFKFred Kato
Open Access
- 29 October 2012
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 356
Abstract
Artemisinin-based combination therapy (ACT), the treatment of choice for uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private sector, the first port of call for most malaria treatment across rural Africa. Between August 2007 and May 2010, the Uganda Ministry of Health and the Medicines for Malaria Venture conducted the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study to test whether access to ACT in the private sector could be improved through the provision of a high level supply chain subsidy.Keywords
This publication has 10 references indexed in Scilit:
- Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in UgandaMalaria Journal, 2012
- A path to an optimal future for the Affordable Medicines Facility – malariaHealth Policy and Planning, 2011
- Universal access to malaria medicines: innovation in financing and deliveryThe Lancet, 2010
- The quest for universal access to effective malaria treatment: how can the AMFm contribute?Malaria Journal, 2010
- Cost is killing patients: subsidising effective antimalarialsThe Lancet, 2009
- Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural TanzaniaPLOS ONE, 2009
- Affordable Medicines Facility for malariaThe Lancet Infectious Diseases, 2009
- A Global Subsidy: Key To Affordable Drugs For Malaria?Health Affairs, 2009
- Malaria case-management under artemether-lumefantrine treatment policy in UgandaMalaria Journal, 2008
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005